Gene Editing for <i>CEP290</i> -Associated Retinal Degeneration
Eric A. Pierce(Broad Institute), Mark E. Pennesi(University of Pennsylvania), Alia Rashid(Penn Presbyterian Medical Center), Keunpyo Kim(Penn Presbyterian Medical Center), Bright S. Ashimatey(Johns Hopkins University), Michael Jaskolka(Editas Medicine (United States)), Steven T. Bailey(Oregon Health & Science University), Andreas Lauer(Legacy Health), Albert M. Maguire(Children's Hospital of Philadelphia), R Myers(Penn Presbyterian Medical Center), Tomás S. Alemán(Children's Hospital of Philadelphia), Byron L Lam(Penn Presbyterian Medical Center), Jason Comander(Massachusetts Eye and Ear Infirmary)
Cited by 209
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k